Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Clinical trial NCT03356769 · UNKNOWN
Trial details
- NCT number
- NCT03356769
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-20
- Primary completion
- 2021-11-20
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.